These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6496159)

  • 1. Dexamethasone suppression test in depression: association with duration of illness.
    Sashidharan SP; Freeman CP; Loudon JB; Novosel S; Beckett GJ; Gray S
    Acta Psychiatr Scand; 1984 Oct; 70(4):354-60. PubMed ID: 6496159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups.
    Mendlewicz J; Charles G; Franckson JM
    Br J Psychiatry; 1982 Nov; 141():464-70. PubMed ID: 7150882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol nonsuppression in depression: relationship to clinical variables.
    Roy A
    J Affect Disord; 1988; 14(3):265-70. PubMed ID: 2968388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of serum dexamethasone concentrations in the dexamethasone suppression test.
    Carr V; Morris H; Gilliland J
    Biol Psychiatry; 1986 Jul; 21(8-9):735-43. PubMed ID: 3730458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone suppression test in panic disorder.
    Judd FK; Norman TR; Burrows GD; McIntyre IM
    Pharmacopsychiatry; 1987 May; 20(3):99-101. PubMed ID: 3602097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dexamethasone test: suppressors and non-suppressors, what's the difference?].
    Vandel S; Bonin B; Vandel B; Allers G; Volmat R
    Encephale; 1985; 11(4):157-62. PubMed ID: 2935387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression.
    Grossman R; Yehuda R; New A; Schmeidler J; Silverman J; Mitropoulou V; Sta Maria N; Golier J; Siever L
    Am J Psychiatry; 2003 Jul; 160(7):1291-8. PubMed ID: 12832244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced adrenal sensitivity to exogenous cosyntropin (ACTH alpha 1-24) stimulation in major depression. Relationship to dexamethasone suppression test results.
    Jaeckle RS; Kathol RG; Lopez JF; Meller WH; Krummel SJ
    Arch Gen Psychiatry; 1987 Mar; 44(3):233-40. PubMed ID: 3030218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms.
    Greenwald BS; Mathé AA; Mohs RC; Levy MI; Johns CA; Davis KL
    Am J Psychiatry; 1986 Apr; 143(4):442-6. PubMed ID: 3953887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test as a biologic marker of depression in chronic pain.
    France RD; Krishnan RRK
    Pain; 1985 Jan; 21(1):49-55. PubMed ID: 3157090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocorticotropin and cortisol response to lysine vasopressin in relation to the outcome of the dexamethasone suppression test in major depressive disorder.
    Akner G; Ljunggren JG; Kjellman BF; Undén F; Wetterberg L
    Acta Psychiatr Scand; 1988 Apr; 77(4):404-10. PubMed ID: 2839010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of corticotropin after administration of corticotropin-releasing hormone in depressed patients in relation to the dexamethasone suppression test.
    Thalén BE; Kjellman BF; Ljunggren JG; Akner G; Kågedal B; Wahlund B; Wetterberg L
    Acta Psychiatr Scand; 1993 Feb; 87(2):133-40. PubMed ID: 8383420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose (0.5-mg) dexamethasone suppression test in depressive patients.
    Sarai M; Matsunaga H
    Biol Psychiatry; 1986 Jul; 21(8-9):744-50. PubMed ID: 3730459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further investigation of the dexamethasone suppression test in affective illnesses: relationship to clinical diagnosis and therapeutic response.
    Mendlewicz J; Hubain PP; Koumakis C
    Neuropsychobiology; 1984; 12(1):23-6. PubMed ID: 6514175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B; Sherman B; Schlechte J; Stone R
    Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine changes and clinical profiles in depression: I. The dexamethasone suppression test.
    Calloway SP; Dolan RJ; Fonagy P; De Souza VF; Wakeling A
    Psychol Med; 1984 Nov; 14(4):749-58. PubMed ID: 6545410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid monoamine and monoamine metabolite levels and the dexamethasone suppression test in depression. Relationship to life events.
    Roy A; Pickar D; Linnoila M; Doran AR; Paul SM
    Arch Gen Psychiatry; 1986 Apr; 43(4):356-60. PubMed ID: 2420302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin response to dexamethasone: a study on normal controls and depressed patients.
    Rupprecht R; Barocka A; Jecht E; Noder M; Pichl J; Schwarz W
    Acta Psychiatr Scand; 1987 Aug; 76(2):139-43. PubMed ID: 3673636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.